News | Breast Imaging | November 25, 2022

New Affirm Contrast Biopsy Technology Included in the Screening, Diagnosis, Treatment

New Affirm Contrast Biopsy Technology Included in the Screening, Diagnosis, Treatment

November 25, 2022 — Hologic, Inc. will exhibit its extensive portfolio of breast and skeletal health products at the 108th Scientific Assembly and Annual Meeting of the Radiological Society of North America (RSNA) from Nov. 27 to Dec. 1. Among the full suite of breast biopsy and surgery solutions will be Hologic’s Affirm Contrast Biopsy software, which will be on display for the first time since becoming commercially available in the United States.

“As the global leader in breast imaging, we are committed to addressing the unmet needs of physicians and their patients across the continuum of breast care and we’re eager to engage with industry leaders at this year’s RSNA meeting to share our vision for the future of breast health,” said Erik Anderson, President of Hologic’s Breast and Skeletal Health Solutions Division. “We are equally excited to showcase our new Affirm Contrast Biopsy technology, which is a great example of our commitment to physicians and patients in action.”

Affirm Contrast Biopsy software allows clinicians to target and acquire tissue samples in lesions identified with I-View Contrast-Enhanced Mammography software. The contrast solution provides healthcare facilities with a viable and attractive alternative to breast MRI, which historically has been used to find and biopsy more elusive lesions, such as those that cannot be seen via mammography or ultrasound. While breast MRI can be time-consuming and costly, contrast technology gives radiologists another option in the mammography suite that addresses these shortcomings.[i],[ii] In a recent clinical study, 98% of patients had an overall positive opinion of their procedure experience with Affirm Contrast Biopsy software.[iii]

RSNA attendees can experience Hologic’s portfolio at Booth 1911 in South Hall Level 3 at McCormick Place in Chicago. In addition to the Affirm Contrast Biopsy software, Hologic will feature its Dimensions mammography portfolio and Supersonic MACH ultrasound systems.

Hologic will also host a series of CME- and non-CME-accredited medical education symposiums and learning opportunities, accessible to attendees on-site and from remote locations. The medical education sessions include:

  • “Upright Biopsy with Brevera Breast Biopsy System: Real-Time Imaging, Verification & Automated Handling”

Sunday, Nov. 27: 11:45 a.m. – 12:45 p.m. CST

Dr. Krystal Airola will demonstrate new upright breast biopsy technologies that will enhance accuracy, workflow and patient experience. She will share her experiences with the Affirm 2D/3D upright biopsy, lateral arm approach and Brevera Breast Biopsy system, which integrates tissue acquisition, real-time imaging and verification, and post-biopsy sample handling. Dr. Airola will also share cases and explain how to significantly reduce the time and discomfort to patients in the biopsy suite while maximizing biopsy suite efficiencies and clinical decision-making.

  • “Emerging Ultrasound Technology in Liver Surveillance”

Monday, Nov. 28: 12:00 p.m. – 1:00 p.m. CST

Learn more about the advancements in ultrasound technology with ShearWave Elastography. There are many opportunities to improve workflow efficiencies in liver surveillance that drive superior patient experiences and outcomes. In this lecture, participants will review comparisons with existing and emerging ultrasound technologies and techniques.

  • “Current AI Applications in Mammography: Focus on Genius AI Detection Software”

Tuesday, Nov. 29: 12:00 p.m. – 1:00 p.m. CST

Attendees will hear from an expert on the benefits of artificial intelligence (AI) in mammography screening. With new high-resolution technologies being implemented, see how AI can reduce dose, file size and reading times. A focus will be on deep-learning AI and the benefits of Genius AI Detection software in clinical decision-making and increasing productivity.

  • “Panel Discussion: Options in Localization”

Wednesday, Nov. 30: 12:00 p.m. – 1:00 p.m. CST

Join a multidisciplinary conversation on localization. Hear perspectives from leading radiologists and breast surgeons about what they like, what they use and why. What is the role of wires? What other technologies are available? What are the strengths and weaknesses of different options?

For more information:


Find more RSNA22 coverage here 


[i] Publication for reference: Kaur, Piccolo, Arasaratnam. Implementation of Contrast-Enhanced Mammography in Clinical Practice, chapter 7, Nori, Kaur (eds.), Contrast-Enhanced Digital Mammography (CEDM). Springer, 2018.

[ii] Hobbs MM, Taylor DB, Buzynski S, and Peake RE. Contrast-enhanced spectral mammography (CESM) and contrast MRI (CEMRI): Patient preferences and tolerance. Journal of Medical Imaging and Radiation Oncology. 2015;59:300-305

[iii] Hologic clinical study CSR-00266 Rev 001 2022




Related Content

Videos | Information Technology

A discussion on macro trends and the future of medical imaging with Jef Williams, managing partner, Paragon Consulting ...

Time February 07, 2023
News | Breast Density

February 6, 2023 — Awareness of breast density appears to increase one’s perceived breast cancer risk for a short time ...

Time February 06, 2023
News | Radiation Therapy

February 2, 2023 — (DBI) announced the results of the study, “Effect of an Educational Intervention ...

Time February 02, 2023
News | MRI Breast

February 1, 2023 — Compared to other common supplemental screening methods, breast MRI was superior at detecting breast ...

Time February 01, 2023
News | Radiation Therapy

February 1, 2023 — Radiotherapy is a crucial component of cancer treatment, used to shrink or destroy tumors with high ...

Time February 01, 2023
Feature | Radiology Business | By Melinda Taschetta-Millane

Here is a recap of what ITN viewers found most interesting during the month of January: 1. A Look at the Changes in 2023 ...

Time February 01, 2023
News | Radiation Therapy

January 31, 2023 — Age-based heuristics can lead to large differences in breast cancer treatment based on small ...

Time January 31, 2023
News | Computed Tomography (CT)

January 30, 2023 — Photon-counting detector CT reduces the amount of contrast needed for CT angiography (CTA) while ...

Time January 30, 2023
Webinar | Information Technology

Postpandemic staffing shortages and increased volumes require radiologists to do more with less, exacerbating burnout ...

Time January 30, 2023
News | Stereotactic Breast Imaging

January 27, 2023 — According to an accepted manuscript published in ARRS’ American Journal of Roentgenology (AJR), both ...

Time January 27, 2023
Subscribe Now